Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/24448Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Ioachim, E. | en |
| dc.contributor.author | Michael, M. | en |
| dc.contributor.author | Katsanos, C. | en |
| dc.contributor.author | Demou, A. | en |
| dc.contributor.author | Tsianos, E. V. | en |
| dc.date.accessioned | 2015-11-24T19:41:08Z | - |
| dc.date.available | 2015-11-24T19:41:08Z | - |
| dc.identifier.issn | 0213-3911 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/24448 | - |
| dc.rights | Default Licence | - |
| dc.subject | Antigens, CD/metabolism | en |
| dc.subject | Antigens, Differentiation, Myelomonocytic/metabolism | en |
| dc.subject | Cell Division | en |
| dc.subject | Epithelium/metabolism | en |
| dc.subject | Female | en |
| dc.subject | HLA-DR Antigens/*metabolism | en |
| dc.subject | Humans | en |
| dc.subject | Immunohistochemistry | en |
| dc.subject | Inflammatory Bowel Diseases/*metabolism | en |
| dc.subject | Intestine, Large/metabolism | en |
| dc.subject | Lymphocyte Subsets/*metabolism | en |
| dc.subject | Male | en |
| dc.subject | Metallothionein/*metabolism | en |
| dc.subject | Middle Aged | en |
| dc.title | The immunohistochemical expression of metallothionein in inflammatory bowel disease. Correlation with HLA-DR antigen expression, lymphocyte subpopulations and proliferation-associated indices | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/12507286 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2003 | - |
| heal.abstract | Metallothionein (MT) expression in intestinal resection specimens from 41 patients with ulcerative colitis (UC) and 10 patients with Crohn's disease (CD ) was immunohistochemically studied by the avidin-biotin (ABC) method. In addition, the possible relationship of its expression with HLA-DR antigen expression, lymphocyte subpopulations and proliferation-associated indices was studied in order to elucidate the role of this molecule in inflammatory bowel disease (IBD). The MT immunoreactivity was recorded by staining and intensity-distribution scores. MT staining varied in and was mainly localized in the cytoplasm, although a combined nuclear/cytoplasmic reactive pattern was also seen in epithelial cells. MT expression was decreased in UC, and CD compared with normal mucosa. No difference in MT expression between UC and CD was noted. In UC, a gradually decreased expression from remission, to resolving and to active phase was observed. An inverse correlation of MT expression with HLA-DR antigen expression was detected (p = 0.018) in the cases of UC. The data suggest that a low level of MT expression in inflammatory bowel disease and particularly in active phase of UC may indicate a decreased endogenous intestinal protection and it may be implicated in the pathogenesis of the disease. | en |
| heal.journalName | Histol Histopathol | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Tsianos-2003-the immunohistochemical expression.pdf | 2.97 MB | Adobe PDF | View/Open Request a copy |
This item is licensed under a Creative Commons License
